Assessing Interocular Symmetry of the Foveal Cone Mosaic.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 12 2020
Historique:
entrez: 17 12 2020
pubmed: 18 12 2020
medline: 13 5 2021
Statut: ppublish

Résumé

To test the hypothesis that foveal cone topography is symmetrical between contralateral eyes. We used adaptive optics scanning light ophthalmoscopy to acquire images of the foveal cone mosaic in each eye of 58 subjects with normal vision (35 female, 23 male). Cones were semiautomatically identified over a 300 × 300-µm foveal area. From these cone coordinates, maps of cone density were derived, and we extracted estimates of peak cone density from each map. Mosaic regularity was assessed using Voronoi cell area regularity (VCAR). Average roundness and average area of the 70%, 75%, 80%, 85%, and 90% of peak density isodensity contours were evaluated. The average peak cone density for right eyes was 180,286 cones/mm2 (n = 49) and for left eyes was 182,397 cones/mm2 (n = 45), with a mean absolute difference of 6363 cones/mm2 (n = 43). Peak density, cone spacing, VCAR, and average area within the isodensity contours of fellow eyes were not significantly different (P = 0.60, P = 0.83, P = 0.30, and P = 0.39, respectively). However, the average roundness of the isodensity contours was 2% more circular in the right eyes than in the left eyes (P = 0.02). There is interocular symmetry of peak foveal cone density, mosaic regularity, and area encompassing the most densely packed cells in subjects with normal vision. The origin and significance of the observed interocular difference in average roundness of the isodensity contours are unclear.

Identifiants

pubmed: 33331861
pii: 2772079
doi: 10.1167/iovs.61.14.23
pmc: PMC7746960
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

23

Subventions

Organisme : NEI NIH HHS
ID : R01 EY024969
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001436
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY017607
Pays : United States
Organisme : NEI NIH HHS
ID : T32 EY014537
Pays : United States
Organisme : NCRR NIH HHS
ID : C06 RR016511
Pays : United States

Références

PLoS One. 2018 Jan 16;13(1):e0191141
pubmed: 29338027
Invest Ophthalmol Vis Sci. 2016 Jun 1;57(7):2992-3001
pubmed: 27273598
Eye (Lond). 2014 Dec;28(12):1488-93
pubmed: 25277309
Adv Exp Med Biol. 2019;1185:133-137
pubmed: 31884601
Graefes Arch Clin Exp Ophthalmol. 1992;230(6):505-10
pubmed: 1427131
Science. 1987 May 1;236(4801):579-82
pubmed: 3576186
Vision Res. 2010 Apr 7;50(8):810-7
pubmed: 20149815
Transl Vis Sci Technol. 2019 Oct 2;8(5):21
pubmed: 31602346
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4457-4466
pubmed: 28863407
Biomed Opt Express. 2016 Nov 03;7(12):4899-4918
pubmed: 28018714
Medicine (Baltimore). 2017 Jun;96(25):e7300
pubmed: 28640147
Ophthalmology. 2014 Jan;121(1):234-245
pubmed: 24148654
Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6858-67
pubmed: 20688730
Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5105-10
pubmed: 21803966
J Vis. 2005 Aug 17;5(7):632-9
pubmed: 16231998
Transl Vis Sci Technol. 2018 Oct 1;7(5):20
pubmed: 30280005
Ophthalmology. 2015 Feb;122(2):326-34
pubmed: 25312043
Retina. 2013 Sep;33(8):1640-9
pubmed: 23538574
Vision Res. 2017 Jan;130:57-66
pubmed: 27887888
Transl Vis Sci Technol. 2017 Apr 3;6(2):9
pubmed: 28392976
Invest Ophthalmol Vis Sci. 2011 Feb 01;52(1):625-34
pubmed: 20861480
Invest Ophthalmol Vis Sci. 2011 Sep 21;52(10):7376-84
pubmed: 21724911
Opt Express. 2010 Nov 22;18(24):24902-16
pubmed: 21164835
Curr Eye Res. 2020 Oct;45(10):1257-1264
pubmed: 32108519
Sci Rep. 2017 Nov 24;7(1):16297
pubmed: 29176721
Am J Ophthalmol. 2015 Aug;160(2):290-300.e1
pubmed: 25935100
Eye (Lond). 2016 Aug;30(8):1135-43
pubmed: 27229708
J Comp Neurol. 1990 Feb 22;292(4):497-523
pubmed: 2324310
Biomed Opt Express. 2011 Jun 1;2(6):1757-68
pubmed: 21698035
Eye (Lond). 2018 Nov;32(11):1723-1730
pubmed: 29993035
Elife. 2019 Jul 26;8:
pubmed: 31348002
Annu Rev Vis Sci. 2015 Nov;1:19-50
pubmed: 26973867
Transl Vis Sci Technol. 2018 Apr 4;7(2):17
pubmed: 29629239
Prog Retin Eye Res. 2013 Jul;35:63-81
pubmed: 23500068
Biomed Opt Express. 2011 Jul 1;2(7):1864-76
pubmed: 21750765
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3759-68
pubmed: 27415794
Prog Retin Eye Res. 2013 May;34:49-77
pubmed: 23219692
Invest Ophthalmol Vis Sci. 1993 Nov;34(12):3278-96
pubmed: 8225863

Auteurs

Jenna A Cava (JA)

Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.

Mitchell T Allphin (MT)

School of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.

Rebecca R Mastey (RR)

Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.

Mina Gaffney (M)

Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.

Rachel E Linderman (RE)

Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.

Robert F Cooper (RF)

Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
Joint Department of Biomedical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, Wisconsin, United States.

Joseph Carroll (J)

Department of Ophthalmology and Visual Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.
Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH